Status:
COMPLETED
Assessment of the New Automated Vitrification System "GAVI" for Early Cleaved Embryos Cryopreservation
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Fertility Disorders
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The meta-analysis comparing the cryopreservation of human embryos by vitrification or slow-freezing suggested that more well design studies as randomized trials are necessary to identify the most succ...
Detailed Description
The last decade has seen a development of a new cryopreservation technique called vitrification. Despite a lack of randomized control trials comparing slow-freezing and vitrification, vitrification se...
Eligibility Criteria
Inclusion
- Couple whose age is \> 18 years and who are included in a IVF procedure with the possibility to cryopreserve embryos according to criteria applied at the hospital of Toulouse
- Signed informed consent by both partners in a couple
- Affiliation to a social security scheme for both partners of the couple
Exclusion
- Couples who does not meet current requirements described by the bioethics law for accession to the ART procedure
- Positive plasma viral load for HIV, hepatitis C virus or hepatitis B virus during the year before the inclusion in one of the couple.
- One of the two partners (or both) is (are) in safeguarding justice, under guardianship or trusteeship.
- Couple included in another interventional study.
Key Trial Info
Start Date :
January 19 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 3 2021
Estimated Enrollment :
423 Patients enrolled
Trial Details
Trial ID
NCT03478592
Start Date
January 19 2018
End Date
February 3 2021
Last Update
October 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital university of Toulouse
Toulouse, France, 31059